| Pathway ID | hsa04014 |
| Pathway Term | Ras signaling pathway |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
|
RASA4 |
RAS p21 protein activator 4 |
10156 |
O43374 |
chr7: 102,573,807-102,616,757 |
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 |
Q7LDG7 |
chr11: 64,726,911-64,745,456 |
|
RALBP1 |
ralA binding protein 1 |
10928 |
Q15311 |
chr18: 9,475,009-9,538,116 |
|
PLA2G16 |
phospholipase A2 group XVI |
11145 |
P53816 |
chr11: 63,573,195-63,616,883 |
|
RASSF1 |
Ras association (RalGDS/AF-6) domain family member 1 |
11186 |
Q9NS23 |
chr3: 50,329,782-50,340,980 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
EFNA1 |
ephrin-A1 |
1942 |
P20827 |
chr1: 155,127,460-155,134,857 |
|
EFNA4 |
ephrin-A4 |
1945 |
P52798 |
chr1: 155,063,731-155,069,553 |
|
EFNA5 |
ephrin-A5 |
1946 |
P52803 |
chr5: 107,376,889-107,670,895 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
ELK1 |
ELK1, member of ETS oncogene family |
2002 |
P19419 |
chrX: 47,635,521-47,650,604 |
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
|
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2113 |
P14921 |
chr11: 128,458,761-128,587,558 |
|
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
2114 |
P15036 |
chr21: 38,805,307-38,824,955 |
|
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
|
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
|
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
|
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
|
FGF12 |
fibroblast growth factor 12 |
2257 |
P61328 |
chr3: 192,139,395-192,767,764 |
|
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
|
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
22800 |
P62070 |
chr11: 14,277,926-14,364,506 |
|
RASA3 |
RAS p21 protein activator 3 |
22821 |
Q14644 |
chr13: 113,977,783-114,132,611 |
|
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
23179 |
Q9NZL6 |
chr1: 183,636,085-183,928,531 |
|
FLT4 |
fms-related tyrosine kinase 4 |
2324 |
P35916 |
chr5: 180,601,506-180,649,624 |
|
GAB1 |
GRB2 associated binding protein 1 |
2549 |
Q13480 |
chr4: 143,336,762-143,474,568 |
|
SHC2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
25759 |
P98077 |
chr19: 416,583-460,996 |
|
ABL2 |
ABL proto-oncogene 2, non-receptor tyrosine kinase |
27 |
P42684 |
chr1: 179,099,327-179,229,684 |
|
GNB1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
2782 |
P62873 |
chr1: 1,785,285-1,891,117 |
|
GNB2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
2783 |
P62879 |
chr7: 100,673,531-100,679,174 |
|
GNB3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
2784 |
P16520 |
chr12: 6,839,954-6,847,393 |
|
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4 |
2786 |
P50150 |
chr1: 235,547,687-235,650,754 |
|
GNG5 |
guanine nucleotide binding protein (G protein), gamma 5 |
2787 |
P63218 |
chr1: 84,498,325-84,506,565 |
|
GNG7 |
guanine nucleotide binding protein (G protein), gamma 7 |
2788 |
O60262 |
chr19: 2,511,219-2,702,709 |
|
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
2791 |
P61952 |
chr7: 93,921,699-93,928,610 |
|
ANGPT1 |
angiopoietin 1 |
284 |
Q15389 |
chr8: 107,249,482-107,498,055 |
|
ANGPT2 |
angiopoietin 2 |
285 |
O15123 |
chr8: 6,499,651-6,563,409 |
|
GRB2 |
growth factor receptor bound protein 2 |
2885 |
P62993 |
chr17: 75,318,076-75,405,709 |
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
2903 |
Q12879 |
chr16: 9,753,404-10,182,754 |
|
TBK1 |
TANK-binding kinase 1 |
29110 |
Q9UHD2 |
chr12: 64,451,880-64,502,108 |
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
3082 |
P14210 |
chr7: 81,699,006-81,770,438 |
|
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
3363 |
P34969 |
chr10: 90,740,823-90,857,698 |
|
IGF1 |
insulin like growth factor 1 |
3479 |
P05019 |
chr12: 102,395,867-102,480,645 |
|
IGF1R |
insulin like growth factor 1 receptor |
3480 |
P08069 |
chr15: 98,648,971-98,964,530 |
|
INS |
insulin |
3630 |
P01308 |
chr11: 2,159,779-2,161,341 |
|
INSR |
insulin receptor |
3643 |
P06213 |
chr19: 7,112,255-7,294,034 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
|
RHOA |
ras homolog family member A |
387 |
P61586 |
chr3: 49,359,145-49,412,998 |
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
|
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
|
FOXO4 |
forkhead box O4 |
4303 |
P98177 |
chrX: 71,096,197-71,103,535 |
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
|
NGF |
nerve growth factor (beta polypeptide) |
4803 |
P01138 |
chr1: 115,285,918-115,338,236 |
|
NGFR |
nerve growth factor receptor |
4804 |
P08138 |
chr17: 49,495,293-49,515,017 |
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
5062 |
Q13177 |
chr3: 196,739,857-196,832,647 |
|
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
5063 |
O75914 |
chrX: 110,944,285-111,227,361 |
|
PLA1A |
phospholipase A1 member A |
51365 |
Q53H76 |
chr3: 119,597,842-119,629,811 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
|
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
5295 |
P27986 |
chr5: 68,215,720-68,301,821 |
|
PLA2G2A |
phospholipase A2 group IIA |
5320 |
P14555 |
chr1: 19,975,431-19,980,416 |
|
PLA2G4A |
phospholipase A2 group IVA |
5321 |
P47712 |
chr1: 186,828,953-186,988,981 |
|
PLA2G5 |
phospholipase A2 group V |
5322 |
P39877 |
chr1: 20,028,179-20,091,190 |
|
PLCG2 |
phospholipase C gamma 2 |
5336 |
P16885 |
chr16: 81,739,097-81,962,693 |
|
PLD1 |
phospholipase D1 |
5337 |
Q13393 |
chr3: 171,600,405-171,810,950 |
|
PRKACA |
protein kinase, cAMP-dependent, alpha catalytic subunit |
5566 |
P17612 |
chr19: 14,091,688-14,118,084 |
|
EXOC2 |
exocyst complex component 2 |
55770 |
Q96KP1 |
chr6: 485,133-693,111 |
|
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
|
PRKCB |
protein kinase C, beta |
5579 |
P05771 |
chr16: 23,836,001-24,220,611 |
|
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
|
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
|
MAPK8 |
mitogen-activated protein kinase 8 |
5599 |
P45983 |
chr10: 48,306,639-48,439,360 |
|
MAPK9 |
mitogen-activated protein kinase 9 |
5601 |
P45984 |
chr5: 180,233,143-180,292,099 |
|
PDGFC |
platelet derived growth factor C |
56034 |
Q9NRA1 |
chr4: 156,760,454-156,971,394 |
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
|
PAK7 |
p21 protein (Cdc42/Rac)-activated kinase 7 |
57144 |
Q9P286 |
chr20: 9,537,389-9,839,041 |
|
BAD |
BCL2 associated agonist of cell death |
572 |
Q92934 |
chr11: 64,269,830-64,284,704 |
|
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11 |
5781 |
Q06124 |
chr12: 112,418,351-112,509,913 |
|
RAB5A |
RAB5A, member RAS oncogene family |
5868 |
P20339 |
chr3: 19,947,079-19,985,175 |
|
RAB5B |
RAB5B, member RAS oncogene family |
5869 |
P61020 |
chr12: 55,973,913-55,996,683 |
|
RAB5C |
RAB5C, member RAS oncogene family |
5878 |
P51148 |
chr17: 42,124,976-42,155,044 |
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 |
P63000 |
chr7: 6,374,523-6,403,977 |
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
5880 |
P15153 |
chr22: 37,225,261-37,244,448 |
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
5881 |
P60763 |
chr17: 82,031,624-82,034,204 |
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 |
P11233 |
chr7: 39,623,483-39,708,124 |
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
5899 |
P11234 |
chr2: 120,240,064-120,294,713 |
|
RALGDS |
ral guanine nucleotide dissociation stimulator |
5900 |
Q12967 |
chr9: 133,097,720-133,149,334 |
|
RAP1A |
RAP1A, member of RAS oncogene family |
5906 |
P62834 |
chr1: 111,542,218-111,716,691 |
|
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1 |
5921 |
P20936 |
chr5: 87,267,888-87,391,931 |
|
RASA2 |
RAS p21 protein activator 2 |
5922 |
Q15283 |
chr3: 141,487,047-141,615,342 |
|
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
5966 |
Q04864 |
chr2: 60,881,521-60,931,610 |
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
6237 |
P10301 |
chr19: 49,635,292-49,640,201 |
|
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 |
Q07889 |
chr2: 38,981,396-39,124,345 |
|
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
6655 |
Q07890 |
chr14: 50,117,120-50,231,558 |
|
STK4 |
serine/threonine kinase 4 |
6789 |
Q13043 |
chr20: 44,966,474-45,079,959 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
7074 |
Q13009 |
chr21: 31,118,416-31,559,977 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
VEGFB |
vascular endothelial growth factor B |
7423 |
P49765 |
chr11: 64,234,538-64,238,793 |
|
VEGFC |
vascular endothelial growth factor C |
7424 |
P49767 |
chr4: 176,683,538-176,792,727 |
|
PDGFD |
platelet derived growth factor D |
80310 |
Q9GZP0 |
chr11: 103,907,186-104,164,379 |
|
CALM2 |
calmodulin 2 |
805 |
P62158 |
chr2: 47,160,082-47,176,601 |
|
CALM3 |
calmodulin 3 |
808 |
P62158 |
chr14: 90,396,502-90,408,261 |
|
PLA2G12A |
phospholipase A2 group XIIA |
81579 |
Q9BZM1 |
chr4: 109,709,989-109,730,077 |
|
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
83593 |
Q8WWW0 |
chr1: 206,507,530-206,589,448 |
|
PLA2G4C |
phospholipase A2 group IVC |
8605 |
Q9UP65 |
chr19: 48,047,843-48,110,817 |
|
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
|
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
8831 |
Q96PV0 |
chr6: 33,419,661-33,457,541 |
|
CALML4 |
calmodulin like 4 |
91860 |
Q96GE6 |
chr15: 68,190,705-68,206,110 |
|
RASAL2 |
RAS protein activator like 2 |
9462 |
Q9UJF2 |
chr1: 178,094,141-178,484,147 |
|
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
|
CDC42 |
cell division cycle 42 |
998 |
P60953 |
chr1: 22,052,627-22,092,946 |